ArticleFrontiers in pediatrics2025
Clinical analysis of laparoscopic pyeloplsty for ureteropelvic junction obstruction in infants under 3 months old.
Article in Frontiers in pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: To evaluate the safety and efficacy of laparoscopic pyeloplasty (LP) in treating ureteropelvic junction obstruction (UPJO) among infants under 3 months of age. Methods: A retrospective analysis was performed on 45 infants with hydronephrosis caused by UPJO treated with LP between January 2019 and December 2024. Patients were divided into two groups by age: 25 infants aged 0-3 months (Group A) and 20 infants aged 4-12 months (Group B). Operative time, hospital stay, complications, anterior-posterior renal pelvic diameter (APD), and minimum renal cortex thickness (Min.RCT) were compared. Results: All procedures were completed laparoscopically without conversion to open surgery. No significant differences were observed between groups in operative time, postoperative hospital stay, complication rates, postoperative APD, or postoperative Min.RCT. Both groups showed significant improvement in APD reduction and Min.RCT increase compared with baseline. During follow-up (6-63 months, median 38.65), no recurrence or reoperation was required. Conclusions: LP is a safe and effective treatment for UPJO in infants ≤3 months with surgical indications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.